Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Bioshares Biotech Clinical Trial (BBC)

38.84   1.03 (2.72%) 09-27 21:55
Open: 38.03 Pre. Close: 37.81
High: 38.84 Low: 37.81
Volume: 19,901 Market Cap: 0M
BBC was created on 12/16/14 by Virtus Investment Partners. The ETF tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 38.87 - 39.128 39.128 - 39.361
Low: 37.172 - 37.501 37.501 - 37.799
Close: 38.239 - 38.76 38.76 - 39.232

Technical analysis

as of: 2020-09-25 4:27:41 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 46.69     One year: 49.79
Support: Support1: 35.67    Support2: 29.68
Resistance: Resistance1: 39.97    Resistance2: 42.63
Pivot: 39.66
Moving Average: MA(5): 39.21     MA(20): 39.62
MA(100): 41.14     MA(250): 35.77
MACD: MACD(12,26): -0.25     Signal(9): -0.13
Stochastic oscillator: %K(14,3): 38.31     %D(3): 48.20
RSI: RSI(14): 44.54
52-week: High: 45.70  Low: 22.92  Change(%): 62.7
Average Vol(K): 3-Month: 2484  10-Days: 1623

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
BBC has closed above bottom band by 36.6%. Bollinger Bands are 41.5% wider than normal. The large width of the bands suggest high volatility as compared to BBC's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue.

Headline News

Mon, 11 May 2020
Biotechnology Sector ETFs Are Leading the Charge - ETF Trends

Thu, 12 Dec 2019
ETF of the Week: Virtus LifeSci Biotech Clinical Trials ETF (BBC) - ETF Trends

Mon, 28 Aug 2017
Biotech ETFs Jump on Gilead, Kite Deal - ETF Trends

Thu, 09 Mar 2017
Trump Tweet On Drug Pricing Hits Biotech And Pharma ETFs - Seeking Alpha

Mon, 19 Sep 2016
Biotechnology ETFs Rally on Sarepta FDA Drug Approval - ETF Trends

Thu, 09 Jun 2016
Wall Street ‘Obesity’ Fund Could Make Your Wallet Fatter - Fortune

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency n/a
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Neutral Discounted cash flow: Neutral
Return on Assets: Neutral Price to Earnings: Neutral
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Shares Out. (M)
Shares Float (M) 1
% Held by Insiders
% Held by Institutions
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales
Price to Cash Flow

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.